Hannover Medical School; Targeting of chemokine receptors may be able to control multiple sclerosis
Hannover Medical School; Targeting of chemokine receptors may be able to control multiple sclerosis
About this item
Full title
Hannover Medical School; Targeting of chemokine receptors may be able to control multiple sclerosis
Publisher
Atlanta: NewsRx
Journal title
Biotech Week, 2004, p.173
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
"Due to broad pharmacological interest in the chemokine system, peptide antagonists and small molecular antagonists are now available for clinical therapeutic trials. For the treatment of MS in particular, the chemokine receptors CCR1, CCR2, CCR5, and CXCR3 are possible targets in a chemokine-based therapeutic approach. We summarize current knowled...
Alternative Titles
Full title
Hannover Medical School; Targeting of chemokine receptors may be able to control multiple sclerosis
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_205605522
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_205605522
Other Identifiers
ISSN
1535-2757
E-ISSN
1537-1395
How to access this item
Log in as a Library member
